15.12.2021 • NewsNovozymesSaipem

Novozymes and Saipem Collaborate on Enzymatic Carbon Capture

Danish biotech Novozymes and Italian engineering company Saipem have agreed to collaborate on the development and commercialization of an enzymatic carbon capture process, a biological alternative to traditional carbon capture.

Saipem has already developed an enzyme-based carbon capture technology, which the two companies will work together to advance. The Italian firm will provide the process and mechanical and equipment design, while Novozymes will supply enzymes for Saipem’s customer base and further optimize the process.

Carbon capture and storage technologies are regarded as an effective route for industrial decarbonization. Traditional processes rely on amines to extract CO2 from flue gas, but enzymatic carbon capture uses carbonates and biological components for the extraction, which it does at lower temperatures. The enzymatic process is also said to be more reliable and less corrosive because it does not use the solvents employed in the traditional route.  

The technology, said Novozymes, has potential to significantly reduce chemical and energy use of the carbon capture process. Simultaneously, using enzymes instead of amines eliminates the need to clean wastewater as they leave no harmful waste products.

Amy Byrick, executive vice president of strategy & business transformation at Novozymes, commented: “As part of our strategy, Novozymes is committed to delivering biological solutions that enable a healthier planet and our collaboration with Saipem helps us fulfil our ambition to explore new growth opportunities while accelerating the battle against climate change.”

Author: Elaine Burridge, Freelance Journalist

(c) Novozymes
(c) Novozymes

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.